Vai al contenuto principale della pagina

Killing Cancer : Discovery and Selection of New Target Molecules



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Kallunki Tuula Visualizza persona
Titolo: Killing Cancer : Discovery and Selection of New Target Molecules Visualizza cluster
Pubblicazione: Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica: 1 online resource (302 p.)
Soggetto topico: Biology, life sciences
Research & information: general
Soggetto non controllato: 3D growth
ABCG2
AF1Q
anoikis
ATP-binding cassette transporter
ATP6V0a3
ATR pathway
autophagy
BRCA1
BRCA2
breast cancer resistance protein (BCRP)
breast cancer stem cells
C2 domain
cancer
cancer metabolism
cancer therapy
CD domain
chondroitin sulfate
colorectal cancer
dexamethasone
disulfiram
DNA damage
drug efflux pumps
dysferlin
EMT
epithelial-mesenchymal transition
ERK1
ERK2
esophageal cancer
ferlin
glucocorticoids
IL-8
immunotherapy
inflammation
invasion
kinase inhibitors
lysosome
lysosome-mediated invasion
mammosphere
MAPK kinase
matrix degradation
metabolism
microgravity
microsatellite instability
migration
MLLT11
mTOR in immunotherapy
mTOR inhibitors
mTOR signaling
mTORC1
mTORC2
multidrug resistance in cancer
myoferlin
MZF1
n/a
NF-κB
NPL4
nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB)
nutrient metabolism
oncofetal chondroitin sulfate
otoferlin
PAK4
PDAC
pediatric cancer
pH-regulation
phosphorylation
plasma membrane
prognosis
proliferation
pyrazolo-pyrimidine derivative
rapalogs
replication stress
Rolled
SCH772984
SCO-201
sevenmaker
solid tumors
space environment
STAT
sulconazole
SUMOylation
target
targeted cancer therapy
TCIRG1
thyroid cancer
transcription factor
VAR2
VRT-11E
WNT
zinc finger
Persona (resp. second.): KallunkiTuula
Sommario/riassunto: Despite the efficiency of current cancer treatments, cancer is still a deadly disease for too many. In 2008, 7.6 million people died of cancer; with the current development, it is estimated that the annual cancer death number will grow to 13 million by 2030. There is clearly a need for not only more research but also more innovative and out of the mainstream scientific ideas to discover and develop even better cancer treatments. This book presents the collective works published in the recent Special Issue entitled "Killing Cancer: Discovery and Selection of New Target Molecules". These articles comprise a selection of studies, ideas, and opinions that aim to facilitate knowledge, thoughts, and discussion about which biological and molecular mechanisms in cancer we should target and how we should target them.
Altri titoli varianti: Killing Cancer
Titolo autorizzato: Killing Cancer  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910557648103321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui